These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29552576)

  • 1. A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials.
    Fraser H; Safinia N; Grageda N; Thirkell S; Lowe K; Fry LJ; Scottá C; Hope A; Fisher C; Hilton R; Game D; Harden P; Bushell A; Wood K; Lechler RI; Lombardi G
    Mol Ther Methods Clin Dev; 2018 Mar; 8():198-209. PubMed ID: 29552576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservation.
    Peters JH; Preijers FW; Woestenenk R; Hilbrands LB; Koenen HJ; Joosten I
    PLoS One; 2008 Sep; 3(9):e3161. PubMed ID: 18776930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good Manufacturing Practice-Compliant Production and Lot-Release of
    Wiesinger M; Stoica D; Roessner S; Lorenz C; Fischer A; Atreya R; Neufert CF; Atreya I; Scheffold A; Schuler-Thurner B; Neurath MF; Schuler G; Voskens CJ
    Front Immunol; 2017; 8():1371. PubMed ID: 29123521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation.
    Safinia N; Vaikunthanathan T; Fraser H; Thirkell S; Lowe K; Blackmore L; Whitehouse G; Martinez-Llordella M; Jassem W; Sanchez-Fueyo A; Lechler RI; Lombardi G
    Oncotarget; 2016 Feb; 7(7):7563-77. PubMed ID: 26788992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical-grade regulatory T cells: Comparative analysis of large-scale expansion conditions.
    Velaga S; Alter C; Dringenberg U; Thiesler CT; Kuhs S; Olek S; Ukena SN; Franzke A
    Exp Hematol; 2017 Jan; 45():27-35.e1. PubMed ID: 27693388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell banking for regulatory T cell-based therapy: strategies to overcome the impact of cryopreservation on the Treg viability and phenotype.
    Gołąb K; Grose R; Placencia V; Wickrema A; Solomina J; Tibudan M; Konsur E; Ciepły K; Marek-Trzonkowska N; Trzonkowski P; Millis JM; Fung J; Witkowski P
    Oncotarget; 2018 Feb; 9(11):9728-9740. PubMed ID: 29515766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
    Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
    Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy.
    Alsuliman A; Appel SH; Beers DR; Basar R; Shaim H; Kaur I; Zulovich J; Yvon E; Muftuoglu M; Imahashi N; Kondo K; Liu E; Shpall EJ; Rezvani K
    Cytotherapy; 2016 Oct; 18(10):1312-24. PubMed ID: 27497700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Process development and validation of expanded regulatory T cells for prospective applications: an example of manufacturing a personalized advanced therapy medicinal product.
    Lavazza C; Budelli S; Montelatici E; Viganò M; Ulbar F; Catani L; Cannone MG; Savelli S; Groppelli E; Lazzari L; Lemoli RM; Cescon M; La Manna G; Giordano R; Montemurro T
    J Transl Med; 2022 Jan; 20(1):14. PubMed ID: 34986854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
    Singh AK; Horvath KA; Mohiuddin MM
    Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A TNFR2-Agonist Facilitates High Purity Expansion of Human Low Purity Treg Cells.
    He X; Landman S; Bauland SC; van den Dolder J; Koenen HJ; Joosten I
    PLoS One; 2016; 11(5):e0156311. PubMed ID: 27224512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated Clinical Grade Expansion of Regulatory T Cells in a Fully Closed System.
    Marín Morales JM; Münch N; Peter K; Freund D; Oelschlägel U; Hölig K; Böhm T; Flach AC; Keßler J; Bonifacio E; Bornhäuser M; Fuchs A
    Front Immunol; 2019; 10():38. PubMed ID: 30778344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of human regulatory T-cells from patients with type 1 diabetes.
    Putnam AL; Brusko TM; Lee MR; Liu W; Szot GL; Ghosh T; Atkinson MA; Bluestone JA
    Diabetes; 2009 Mar; 58(3):652-62. PubMed ID: 19074986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Freezing Medium Containing 5% DMSO Enhances the Cell Viability and Recovery Rate After Cryopreservation of Regulatory T Cell Products
    Kaiser D; Otto NM; McCallion O; Hoffmann H; Zarrinrad G; Stein M; Beier C; Matz I; Herschel M; Hester J; Moll G; Issa F; Reinke P; Roemhild A
    Front Cell Dev Biol; 2021; 9():750286. PubMed ID: 34926446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35.
    Ulbar F; Villanova I; Giancola R; Baldoni S; Guardalupi F; Fabi B; Olioso P; Capone A; Sola R; Ciardelli S; Del Papa B; Brattelli A; Ricciardi I; Taricani S; Sabbatinelli G; Iuliani O; Passeri C; Sportoletti P; Santarone S; Pierini A; Calabrese G; Falzetti F; Bonfini T; Accorsi P; Ruggeri L; Martelli MF; Velardi A; Di Ianni M
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2204-2210. PubMed ID: 32961369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and expansion of thymus-derived regulatory T cells for use in pediatric heart transplant patients.
    Romano M; Sen M; Scottà C; Alhabbab RY; Rico-Armada A; Lechler RI; Burch M; Lombardi G
    Eur J Immunol; 2021 Aug; 51(8):2086-2092. PubMed ID: 33949684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of Human Tregs from Cryopreserved Umbilical Cord Blood for GMP-Compliant Autologous Adoptive Cell Transfer Therapy.
    Seay HR; Putnam AL; Cserny J; Posgai AL; Rosenau EH; Wingard JR; Girard KF; Kraus M; Lares AP; Brown HL; Brown KS; Balavage KT; Peters LD; Bushdorf AN; Atkinson MA; Bluestone JA; Haller MJ; Brusko TM
    Mol Ther Methods Clin Dev; 2017 Mar; 4():178-191. PubMed ID: 28345003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.
    Keever-Taylor CA; Browning MB; Johnson BD; Truitt RL; Bredeson CN; Behn B; Tsao A
    Cytotherapy; 2007; 9(2):144-57. PubMed ID: 17453966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of leukapheresis and CD4 positive selection in Treg isolation and the ex-vivo expansion for a clinical application in transplantation and autoimmune disorders.
    Gołąb K; Grose R; Trzonkowski P; Wickrema A; Tibudan M; Marek-Trzonkowska N; Matosz S; Solomina J; Ostrega D; Michael Millis J; Witkowski P
    Oncotarget; 2016 Nov; 7(48):79474-79484. PubMed ID: 27821811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.